The Effect of MS14 on Production of Pro-inflammatory Cytokines by Macrophages

Document Type : Original Article


1 Department of Immunology, Medical School and Medicinal Plant Research Center, Shahed University, Tehran, Iran

2 Department of biology, faculty of Basic Sciences, Shahid Bahonar University, Kerman, Iran

3 Department of Pharmacology and Department of Iranian Traditional Medicine, Medical School, Shahed University, Tehran, Iran


Using herbal medicines as a complementary treatment method is increasing in wide variety of diseases. MS14-an herbal-marine preparation-is reported to have anti-inflammatory and immunomodulatory activities; however, the mechanism underlying its therapeutic effect is not known. Macrophages play an important role in host defense mechanisms and carry out their role by producing various mediators including proinflammatory cytokines (TNFα, IL-1β). In this study the effects of orally administered MS14 on TNFα and IL-1β production of BALB/c mice peritoneal macrophages were evaluated.
Materials and Methods
MS14 at 100 mg/kg was orally administered for 5 days to BALB/c mice in MS14 group. Sterile normal
saline was administered to mice in control group. Peritoneal macrophage were isolated from control and MS14 groups and cultured, then the supernatants were collected and the cytokines IL-1β and TNFα were measured by ELISA test.
Significant decrease in TNFα and IL-1β production of macrophages both at the presence and absence of stimulators was observed. TNFα levels were 64.7±4.6 and 51.1±4.2 pg/ml in drug and control groups respectively (P< 0.05) and 298.7±31.3 and 177.0±26.5 pg/ml in stimulated (PMA+fMLP) cultures of drug and control groups respectively (P< 0.007). The IL-1β levels was 130.1±2.8 pg/ml in control and 65.1±5.6 in MS14 group (P< 0.000).
It could be concluded that MS14 is able to cause a decline in some inflammatory responses of immune system, which could be considered as at least one of its immunomodulatory mechanisms.


1. Choi CY, Kim JY, Kim YS, Chung YC, Seo JK, Jeong HG. Aqueous extract isolated from Platycodon grandiflorum elicits the release of nitric oxide and tumor necrosis factor- a frommurine macrophages. Int Immunopharmacol 2001; 1:1141–1151.
2. Cope AP. Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 1998; 10:669-676.
3. Iorioa AD, Ferruccib L, Sparvieria E, Cherubinic A,Volpatod S, Corsib A, et al. Serum IL-1b levels in health and disease:a population-based study. InCHIANTI study. Cytokine 2003; 22:198–205.
4. Werner GH, Jolles P.Immunstimulating agent:what next? Eur J Biochem 1996; 242:1-19.
5. Henderson L,Yue QY, Bergquist C, Gerden B, Arlett P. St John’s wort (Hypericum perforatum): drug interactions and clinicaloutcomes. Br J Clin Pharmacol 2002; 54: 349–356.
6. Naseri M, Ahmadi A, Ghareghozli K, Nabavi M, Faghiehzade S, Ashtarian N. Clinical and toxicitology evaluation of MS14 natural product in patients with Multiple sclerosis. Daneshvar 2007; 68:59-64.
7. Tafreshi AP, Ahmadi A, Ghaffarpur M, Mostsfavi H, Rezaeizadeh H, Minaie B, et al. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother Res 2008; 22:1083-1086.
8. Hajhashemi V, Ghafghazi T, Ahmadi A. Investigation of subacute toxicity of MS14 natural drug in rat. Daneshvar 2004; 11:11-14.
9. Tripathi S, Bruch D, Kittur DS. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Alter Med 2008; 8:1.
10. Kim SJ, Jeong H-J, Moon PD, Lee L, Jung HJ, et al. Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor- kB activation in peritoneal macrophages. Biol Pharm Bull 2005; 28:233-237.
11. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008; 252:91-110.
12. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118:3537-3545
13. Anolik JH. B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis 2007; 65:182-186.
14. Imitola J, Chitnis T, Khoury S. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 2005; 106:163-177.
15. Calixto JB, Campos MM, Otuki MF, Santos AR. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004; 70:93-103.
16. Sedaghat R, Yaraee R, Naseri M, Naghizadeh MM. The effect of MS14 on body weight, spleen index and structures of kidney, liver, spleen, lung, lymph node and bone marrow histology in Balb/c mice. Pajouhesh dar pezeshki (Journal of Research In Medical Sciences) 2010; 34:8-12.
17. Hammer KDP, Hillwig ML, Solco AKS, Dixon PM. Inhibition of prostaglandin E2 production by anti-inflammatory hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells. J Agric Food Chem 2007; 55:7323–7331.
18. Mencherini T, Cau A, Bianco G, Della Loggia R, Aquino RP, Autore G. An extract of Apium graveolens var. dulce leaves: structure of the major constituent, apiin, and its anti-inflammatory properties. J Pharm Pharmacol 2007; 59:891-897.
19. Eghtedardoost M, Yaraee R, Ghazanfari T, Naseri M. The Effect of MS14 on Candidial sepsis in BALB/C mice. Iran J Infect Dis Trop Med 2009; 14:1-6.
20. Yaraee R, Naseri M, Eghtedardoost M, Ahmadi A. The Effect of MS14 on Th2 cytokines pattern in BALB/C mice. Immunopharmacol Immunotoxicol 2010; 32:450-453.